Study Will Also Evaluate Safety and Efficacy of the Stent System in Association With Use of the Passeo-35 Xeo Peripheral Dilatation Catheter
BIOTRONIK is proud to announce the enrollment of the first patient in the BIONETIC-I study of the safety and efficacy of the Dynetic®-35 cobalt chromium balloon-expandable stent system for the treatment of atherosclerotic peripheral artery disease lesions in the iliac arteries. The study will also evaluate the use of the stent system in association with BIOTRONIK’s Passeo®-35 Xeo* peripheral dilatation catheter. The first patient was enrolled by investigator Dr. Koen Keirse, Vascular Surgeon at the Tienen Medical Center in Tienen, Belgium.